Addressing the toughest challenges in CNS studies
Sponsors and CROs face challenges and high risks in the design and execution of clinical trials in support of new CNS therapies. The likelihood of a clinical success is narrow, and the variability of data generated in the study only exacerbates the challenges.
Meanwhile, the identification and training of sites in the execution of CNS studies have grown even more complex. Sponsors need to know the right scales, technologies, and reviews are in place to ensure the data is high-quality and analyzed appropriately.
Our CNS solution is a modular suite of services that apply the clinical expertise of WCG scientists and clinicians to mitigate the risks of bias, variability, and human error, while addressing the root causes of failed and inconclusive CNS trials.
The CNS expertise your trial requires
Our solutions for CNS studies draw on our legacy delivering true outcomes for some of the most subjective and complex indications, including psychiatric, neurodegenerative, and pain clinical trials.
Our neuroscience leaders have helped sponsors and CROs reduce the risk of trial failure by supporting the science, data integrity, and approval of vital CNS therapies. From our purpose-built CNS technology to our ability to support global operations with scientific oversight, we have brought together world-renown minds to help you carry out confident decision-making in CNS drug development.
global Alzheimer’s Disease trials supported in the last five years
global Parkinson’s Disease trials supported in the last five years
up to 85% reduction in error rates for endpoints with our eCOA solution
active neurology and psychiatry sites worldwide
A suite of five solutions to accelerate CNS studies
Endpoint Selection and Management
Study Insight Analytics
Let’s discuss how you can improve signal detection on your CNS study
A short conversation will help assess your needs and how WCG can assist. To arrange a call with one of our CNS experts, simply fill out this form.